David Cooper
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Antimicrobial Resistance in Staphylococcus
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 detection and testing
- Microbiology top 2%
Papers in
- Epidemiology 36
- Respiratory viral infections research 21
- Pneumonia and Respiratory Infections 13
-
- Antimicrobial Resistance in Staphylococcus 10
- SARS-CoV-2 and COVID-19 Research 8
- Co-authors
- Kathrin U. Jansen (17 shared papers)Kena A. Swanson (21 shared papers)Philip R. Dormitzer (10 shared papers)Mark Cutler (9 shared papers)Pei‐Yong Shi (7 shared papers)Xuping Xie (7 shared papers)Jing Zou (7 shared papers)Hongjie Xia (6 shared papers)
- Journals
- Vaccine (9 papers)Open Forum Infectious Diseases (9 papers)Human Vaccines & Immunotherapeutics (5 papers)The Journal of Infectious Diseases (5 papers)Journal of Virology (4 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
David Cooper
51 papers receiving 2.3k citations
David Cooper's Hit Papers
Peers
Comparison fields: 5 of 108
- Infectious Diseases 1.3k
- Microbiology 209
- Epidemiology 827
- Animal Science and Zoology 212
- Virology 81
Countries citing papers authored by David Cooper
This map shows the geographic impact of David Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cooper more than expected).
Fields of papers citing papers by David Cooper
This network shows the impact of papers produced by David Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cooper. The network helps show where David Cooper may publish in the future.
Co-authors
The 25 scholars most cited alongside David Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera Hit paper breakdown → | 2021 | 383 |
| 2 | BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants Hit paper breakdown → | 2021 | 212 |
| 3 | 2011 | 191 | |
| 4 | 1983 | 136 | |
| 5 | 2016 | 115 | |
| 6 | 2013 | 97 | |
| 7 | 2012 | 81 | |
| 8 | 2006 | 73 | |
| 9 | 2007 | 73 | |
| 10 | 1991 | 69 | |
| 11 | 2021 | 67 | |
| 12 | 2022 | 64 | |
| 13 | 2021 | 58 | |
| 14 | 2017 | 57 | |
| 15 | 2006 | 57 | |
| 16 | 2015 | 50 | |
| 17 | 2016 | 43 | |
| 18 | 2022 | 41 | |
| 19 | 2015 | 37 | |
| 20 | 2021 | 31 |
About David Cooper
David Cooper is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Animal Science and Zoology and Genetics, having authored 57 papers that have together received 2.4k indexed citations. Recurring topics across this work include Respiratory viral infections research (21 papers), Pneumonia and Respiratory Infections (13 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Animal Virus Infections Studies (8 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Bacterial Infections and Vaccines (7 papers), Bacterial biofilms and quorum sensing (6 papers) and Virus-based gene therapy research (6 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), Microbiology (209 citations), Epidemiology (827 citations), Animal Science and Zoology (212 citations) and Virology (81 citations). David Cooper has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Kathrin U. Jansen, Kena A. Swanson, Philip R. Dormitzer, Mark Cutler, Pei‐Yong Shi, Xuping Xie, Jing Zou, Hongjie Xia, Annaliesa S. Anderson and Kathrin U. Jansen. Their work appears in journals such as Vaccine, Open Forum Infectious Diseases, Human Vaccines & Immunotherapeutics, The Journal of Infectious Diseases and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.